TaVNS added to physiotherapy for adhesive capsulitis
Official title: Effect of Transcutaneous Auricular Vagus Nerve Stimulation Added to Standard Physiotherapy on Pain, Function, and Quality of Life in Patients With Shoulder Adhesive Capsulitis: A Randomized Controlled Trial
Run by Liv Hospital Vadistanbul · NCT07711353 · Data updated 2026-11-12
This study tests whether adding a tVNS treatment to standard physiotherapy helps adults with adhesive capsulitis reduce pain and improve shoulder function.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 40 (estimated) |
| Sponsor | Liv Hospital Vadistanbul Academic / other |
| Locations | 1 site (Istanbul, Istanbul) |
| Status | Recruiting |
| Started | June 10, 2026 |
| Main results expected | October 1, 2026 |
| Study ends | October 1, 2026 |
| Registry record updated | July 17, 2026 |
| Trial ID | NCT07711353 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18–65 with a clinical diagnosis of adhesive capsulitis, at least 3 months of shoulder pain and ROM limitation, and able to participate in physiotherapy and taVNS/sham procedures.
✕Probably not a fit
Individuals with shoulder conditions caused by trauma, surgery, infection, tumor, or inflammatory rheumatic diseases, or those who recently had shoulder injections or surgery, may derive little to no benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized, sham-controlled trial will compare active transcutaneous auricular vagus nerve stimulation (taVNS) plus standard physiotherapy to sham taVNS plus the same physiotherapy in adults with adhesive capsulitis. Forty participants, aged 18 to 65, will receive 15 sessions of physiotherapy over 3 weeks, with either active or sham taVNS for 30 minutes daily. Outcomes include changes in pain, shoulder disability, range of motion, and health-related quality of life, assessed before treatment and after the 15th session. The study aims to determine if taVNS provides additional benefit when combined with conventional rehabilitation. Safety and tolerability of the combined approach will also be monitored.
Why it matters
Potential benefit: If successful, patients may experience greater pain relief and improved shoulder function when taVNS is added to rehabilitation.
How similar studies have gone: Evidence for taVNS in adhesive capsulitis is limited, but neuromodulation approaches have shown promise in other chronic pain conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age between 18 and 65 years. * Clinical diagnosis of adhesive capsulitis confirmed by physical examination and, when clinically indicated, imaging. * Shoulder pain and limitation of shoulder range of motion for at least 3 months. * Provision of written informed consent. * General health status sufficient to participate in standard physiotherapy and active or sham transcutaneous auricular vagus nerve stimulation. * Ability to comply with the planned treatment sessions and outcome assessments. Exclusion Criteria: * Shoulder stiffness secondary to trauma, surgery, infection, or tumor. * Rotator cuff tear, advanced glenohumeral osteoarthritis, or inflammatory rheumatic disease. * Glucocorticoid injection into the affected shoulder within the previous 3 months. * Surgical intervention involving the affected shoulder within the previous 6 months. * Active infection or skin lesion in the shoulder region. * Cervical radiculopathy, brachial plexopathy, stroke, or another neurological disorder affecting the upper extremity. * Presence of a cardiac pacemaker or another implanted electronic device. * Pregnancy or breastfeeding. * Serious systemic disease or cognitive impairment that may prevent compliance with the study protocol. * Known intolerance or previous adverse reaction to transcutaneous electrical stimulation.
Where it's running
-
Liv hospital Vadistanbul
Istanbul, Istanbul, Turkey (Türkiye) Recruiting
Study contacts
- Principal investigator: Muhsin Doran — Liv Hospital Vadistanbul
- Study coordinator: Muhsin Doran, MD
- Email: muhsin-doran@hotmail.com
- Phone: 05340807940
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nexsphere-F arterial embolization for chronic frozen shoulder pain
We will try a minimally invasive arterial embolization using Nexsphere-F to reduce pain in adults with frozen shoulder that hasn’t improved with usual care.
-
Hormone Replacement Therapy added to standard care for frozen shoulder in peri- or postmenopausal women
This study tests whether adding hormone replacement therapy to standard treatment helps reduce pain and stiffness from frozen shoulder in peri- or postmenopausal women.
-
Comparing two doses of corticosteroids for frozen shoulder treatment
This study is testing whether two different doses of a steroid injection can help people with frozen shoulder feel less pain and move their shoulder better.
-
Evaluating non-invasive neurostimulation for frozen shoulder treatment
This study is testing if a new non-invasive treatment using brain stimulation and tendon vibration can help people with frozen shoulder feel better compared to a placebo.
-
Evaluating robotic training for shoulder adhesive capsulitis
This study is testing if robotic training can help adults with shoulder pain and movement issues recover better than regular rehab methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.